Intranasal Insulin and Olanzapine Study in Healthy Volunteers

NCT03741478 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Healthy Controls

Interventions

DRUG: OLANZapine 2.5 MG
DRUG: Placebo
DRUG: Insulin Lispro 100 UNT/ML
OTHER: Saline

Sponsor

Centre for Addiction and Mental Health

Collaborators

[object Object]